<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">128</article-id>
<title-group><article-title>Review on medicated nail lacquer for onychomycosis, the carrier system is transungual delivery system for antifungal drug</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Fotedar</surname><given-names>Shivani</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Chouhan</surname><given-names>Sakshi Singh</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Namdev</surname><given-names>Anshul</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Madhuri</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Priyanka</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>Assistant Professor, Department of Pharmaceutics, Chameli Devi Institute of Pharmacy, Indore, Madhya Pradesh, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2022</year></pub-date>
<volume>3</volume>
<issue>2</issue>
<fpage>42</fpage>
<lpage>48</lpage>
<history>
<date date-type="received"><day>08</day><month>05</month><year>2022</year></date>
<date date-type="accepted"><day>25</day><month>05</month><year>2022</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/128/review-on-medicated-nail-lacquer-for-onychomycosis-the-carrier-system-is-transungual-delivery"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/128/download"/>
<abstract><p>The objective if written review paper on antifungal nail lacquer which is used in treatment of onychomycosis nail fungal disorder was focus on the disease causes and treatment by nail lacquer, onychomycosis is common fungal nail infection causes by the pathogens. In this article several methods are described for the drug delivery through nail by incorporating the permeability enhancer. Nail lacquer is mostly applicable for those drugs which have poor bioavailability in oral formulation this technique is used to maximize the topical bioavailability of drug across the nail. In this luliconazole nail lacquer is described for onychomycosis. The high permeation rate helps to reduce the treatment period for the disease.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Nail lacquer</kwd><kwd>luliconazole</kwd><kwd>castor oil</kwd><kwd>methanol</kwd><kwd>toluene</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Kassan DG, Lynch AM, Stiller MJ. Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis. J. Am. Acad. Dermatol. 1996: 34 (4):657-666.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Behl PN. Abrasion in the treatment of nail disorders. Indian J. Dermatol. 1973: 18:77-79. International Journal of Medical and All Body Health Research www.allmedicaljournal.com</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Mohorcic M, Torkar A, Friedrich J, Kristl J, Murdan S. An investigation into keratinolytic enzymes to enhance ungual drug delivery. Int. J. Pharm. 2007; 332:196-201.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Malhotra GG, Zatz JL. Investigation of nail permeation enhancement by chemical modification using water as a probe. J. Pharm. Sci. 2002: 91:312-323.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Hui X, Wester RC, Barbadillo S, Lee C, Patel B, Wortzmman M, Gans EH, Maibach HI. Ciclopirox delivery into the human nail plate. J. Pharm. Sci. 2004:93</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Wang JCT, Sun Y. Human nail and its topical treatment: brief review of current research and development of topical antifungal drug delivery for onychomycosis treatment. J. Cosmet. Sci. 1998: 71-76.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Walters KA, Flynn GL, Marvel JR. Penetration of the human nail plate: the effects of vehicle pH on the permeation of miconazole. J. Pharm. Pharmacol. 1985:37; 498-499.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Hao J, Li SK. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. J. Pharm. Sci. 2008: 97:893-905.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Murthy SN, Wiskirchen DE, Bowers CP. Iontophoretic drug delivery across human nail. J. Pharm. Sci. 2007; 96:305-311.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Di Chiacchio N, Kadunc BV, De Almeida AR, Madeira CL. Nail abrasion. J. Cosmet. Dermatol. 2003: 2:150-152.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>De Berker DAR, Baran R, Dawber RPR. Infections involving the nail unit. In: Handbook of Diseases of the Nails and their Management. Blackwell Science Ltd, Oxford, 1973, 53-63.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Brown MB, Khengar RH, Turner RB, Forbes B, Traynor MJ, Evans CR, Jones SA. overcoming the nail barrier: a systematic investigation of ungula chemical penetration enhancement. Int. J. Pharm. 2009; 370:61-67.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Behl PN. Abrasion in the treatment of nail disorders. Indian J. Dermatol. 1973; 18:77-79.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Sabreen J, Divyakumar B, Kiran B. Preungual, Drug Delivery Systems of Terbinafine Hydrochloride Nail Lacquer. Asian J Pharm. 2008; 02:53-66.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Arun Raj RJH. Enhancement of Bioavailability of Carvedilol Using Solvent Deposition Techniques. Int J Pharm Sci Res. 2017; 8(8):3391-401.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Rich P, Scher RK. An Atlas of Diseases of Nail, New York: Encyclopedia of Visual Medicine Series, Parthenon Publishing Group, 2005.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Gupchup GV, Zatz JL. Structural Characteristics and Permeability Properties of the Human Nail: A Review, J Cosmet Sci. 1999; 50:363-385.</mixed-citation></ref>
</ref-list></back>
</article>